Literature DB >> 33246893

Neurologist prescribing versus psychiatry referral: Examining patient preferences for anxiety and depression management in a symptomatic epilepsy clinic sample.

Heidi M Munger Clary1, Rachel D Croxton2, Beverly M Snively3, Gretchen A Brenes4, James Lovato5, Fatemeh Sadeghifar6, James Kimball7, Cormac O'Donovan8, Kelly Conner9, Esther Kim10, Jonathan Allan11, Pamela Duncan12.   

Abstract

OBJECTIVE: Anxiety and depression symptoms in epilepsy are common, impactful and under-recognized and undertreated. While prior survey data suggests equipoise among epileptologists for managing anxiety and/or depression via prescribing in the epilepsy clinic versus psychiatry referral, patient preferences are unknown and should potentially influence practice habits among epileptologists. Thus, the primary objective of this study was to determine patient preference for anxiety and/or depression prescribing by neurologists versus psychiatry referral among an adult epilepsy clinic sample of symptomatic patients.
METHODS: Management preferences for anxiety and/or depression were surveyed in an adult tertiary care epilepsy clinic. Individuals who screened positive for anxiety and/or depression symptoms on validated instruments during a routine care-embedded learning health system study were recruited. Demographics, social variables, psychiatric treatment history, and treatment priorities and preferences were surveyed. Preference was defined as a slightly greater than 2:1 ratio in favor neurology prescribing or psychiatry referral. The study was powered to assess this primary objective using a two-sample binomial test. Multinomial logistic regression examined an a priori multivariable model of treatment preference (secondary objective).
RESULTS: The study sample included N = 63 symptomatic adults, with 64% women and mean age 42.2 years. Most reported past or current treatment for anxiety and/or depression, and treatment for these symptoms was a high or moderate priority among 65.1% of the sample. Neurologist prescribing was preferred in 83.0% (nearly 5:1) over psychiatry referral among those who chose neurology or psychiatry (as opposed to neither of the two; p < 0.001, 95% CI 0.702-0.919). Overall, 69.8% of the total study sample preferred neurology prescribing. Multivariable modeling indicated preference for neither management option (compared with neurologist prescribing) was associated with low overall treatment prioritization and having never received neurologist medication management. None of the factors examined in the a priori multivariable model were associated with selecting psychiatry referral (compared to neurologist prescribing).
CONCLUSION: In this sample, most patients indicated a preference for neurologists to prescribe for anxiety or depression symptoms in the epilepsy clinic. Care models involving neurologist prescribing for anxiety and depression symptoms merit further investigation and potential adoption in clinical practice.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; Depression; Epilepsy; Neurologist; Patient treatment preferences; Psychiatrist

Mesh:

Year:  2020        PMID: 33246893      PMCID: PMC7855561          DOI: 10.1016/j.yebeh.2020.107543

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  43 in total

1.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

2.  Who is willing to participate in research? A screening model for an anxiety and depression trial in the epilepsy clinic.

Authors:  Heidi M Munger Clary; Rachel D Croxton; Jonathan Allan; James Lovato; Gretchen Brenes; Beverly M Snively; Mingyu Wan; James Kimball; Matthew H Wong; Cormac A O'Donovan; Kelly Conner; Victor Jones; Pamela Duncan
Journal:  Epilepsy Behav       Date:  2020-01-27       Impact factor: 2.937

3.  Patient versus neurologist preferences: A discrete choice experiment for antiepileptic drug therapies.

Authors:  Alan B Ettinger; John A Carter; Krithika Rajagopalan
Journal:  Epilepsy Behav       Date:  2018-02-10       Impact factor: 2.937

4.  Anxiety and depressive disorders in people with epilepsy: A meta-analysis.

Authors:  Amelia J Scott; Louise Sharpe; Caroline Hunt; Milena Gandy
Journal:  Epilepsia       Date:  2017-05-03       Impact factor: 5.864

5.  Epilepsy is associated with unmet health care needs compared to the general population despite higher health resource utilization--a Canadian population-based study.

Authors:  Aylin Y Reid; Amy Metcalfe; Scott B Patten; Samuel Wiebe; Sophie Macrodimitris; Nathalie Jetté
Journal:  Epilepsia       Date:  2012-01-05       Impact factor: 5.864

6.  Choice and control: how involved are people with epilepsy and their families in the management of their epilepsy? Results from an Australian survey in the disability sector.

Authors:  Michelle Bellon; Wayne Pfeiffer; Vanessa Maurici
Journal:  Epilepsy Behav       Date:  2014-08-02       Impact factor: 2.937

7.  Concurrent and predictive validity of a self-reported measure of medication adherence.

Authors:  D E Morisky; L W Green; D M Levine
Journal:  Med Care       Date:  1986-01       Impact factor: 2.983

8.  Epilepsy care and mental health care for people with epilepsy: California Health Interview Survey, 2005.

Authors:  Alexander W Thompson; Rosemarie Kobau; Royce Park; David Grant
Journal:  Prev Chronic Dis       Date:  2012-02-23       Impact factor: 2.830

9.  Premature mortality in epilepsy and the role of psychiatric comorbidity: a total population study.

Authors:  Seena Fazel; Achim Wolf; Niklas Långström; Charles R Newton; Paul Lichtenstein
Journal:  Lancet       Date:  2013-07-22       Impact factor: 79.321

10.  Quality improvement in neurology: Epilepsy Quality Measurement Set 2017 update.

Authors:  Anup D Patel; Christine Baca; Gary Franklin; Susan T Herman; Inna Hughes; Lisa Meunier; Lidia M V R Moura; Heidi Munger Clary; Brandy Parker-McFadden; Mary Jo Pugh; Rebecca J Schultz; Marianna V Spanaki; Amy Bennett; S Andrew Josephson
Journal:  Neurology       Date:  2018-10-03       Impact factor: 9.910

View more
  2 in total

1.  The Decline of Screening: Psychiatry is Just Not that Simple.

Authors:  Jay A Salpekar
Journal:  Epilepsy Curr       Date:  2021-06-28       Impact factor: 7.500

2.  Patient-reported outcomes via electronic health record portal versus telephone: a pragmatic randomized pilot trial of anxiety or depression symptoms in epilepsy.

Authors:  Heidi M Munger Clary; Beverly M Snively; Umit Topaloglu; Pamela Duncan; James Kimball; Halley Alexander; Gretchen A Brenes
Journal:  JAMIA Open       Date:  2022-10-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.